ߜ Monitoring of cerebral oxygenation is considered to be of great importance in minimizing secondary hypoxic and ischemic brain damage following severe head injury. Although the threshold for cerebral hypoxia in jugular bulb oximetry (measurement of O 2 saturation in the jugular vein (SjvO 2 )) is generally accepted to be 50% oxygen saturation, a comparable value in brain tissue PO 2 (PtiO 2 ) monitoring, a new method for direct assessment of PO 2 in the cerebral white matter, has not yet been established. Hence, the purpose of this study was to compare brain PtiO 2 with SjvO 2 in severely head injured patients during phases of reduced cerebral perfusion pressure (CPP) to define a threshold in brain PtiO 2 monitoring. In addition, the safety and data quality of both SjvO 2 and brain PtiO 2 monitoring were studied.
In 15 patients with severe head injuries, SjvO 2 and brain PtiO 2 were monitored simultaneously. For brain PtiO 2 monitoring a polarographic microcatheter was inserted in the frontal cerebral white matter, whereas for SjvO 2 measurements were obtained by using a fiberoptic catheter placed in the jugular bulb. Intracranial pressure was monitored by means of an intraparenchymal catheter. Mean arterial blood pressure, CPP, end-tidal CO 2 , and arterial oxygen saturation (pulse oximetry) were continuously recorded. All data were simultaneously stored and analyzed using a multimodal computer system. For specific analysis, phases of marked deterioration in systemic blood pressure and consecutive reductions in CPP were investigated.
There were no complications that could be attributed to the PtiO 2 catheters, that is, no intracranial bleeding or infection. The "time of good data quality" was 95% in brain PtiO 2 compared to 43% in SjvO 2 ; PtiO 2 monitoring could be performed twice as long as SjvO 2 monitoring. During marked decreases in CPP, SjvO 2 and brain PtiO 2 correlated closely. A significant second-order regression curve of SjvO 2 versus brain PtiO 2 (p Ͻ 0.01) was plotted. At a threshold of 50% in SjvO 2 , brain PtiO 2 was found to be within the range of 3 to 12 mm Hg, with a regression curve "best fit" value of 8.5 mm Hg. There was a close correlation between CPP and oxygenation parameters (PtiO 2 and SjvO 2 ) when CPP fell below a breakpoint of 60 mm Hg, suggesting intact cerebral autoregulation in most patients.
This study demonstrates that monitoring brain PtiO 2 is a safe, reliable, and sensitive diagnostic method to follow cerebral oxygenation. In comparison to SjvO 2 , PtiO 2 is more suitable for long-term monitoring. It can be used to minimize episodes of secondary cerebral maloxygenation after severe head injury and may, hopefully, improve the outcome in severely head injured patients. To define a critical threshold in brain PtiO 2 , simultaneous measurements of SjvO 2 and brain PtiO 2 were performed. Analyses focused particularly on accidental episodes of arterial hypotension, that is, reduced CPP. In addition, safety of the monitoring technique as well as the data quality of SjvO 2 and PtiO 2 were compared and evaluated.
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Clinical Material and Methods
Patient Characteristics and Early Posttraumatic Management
In this study 15 patients with severe head injury were investigated. Permission to measure PtiO 2 was granted by the local ethics committee. The median Glasgow Coma Scale score in this group on admission was 5 (range 4-8). All patients had been intubated and ventilated on the scene. After resuscitation, cranial computerized tomography (CT) was performed. Space-occupying lesions that were greater than 25 ml were evacuated immediately. Patients were classified according to group as "evacuated mass lesion" (six cases), "diffuse injury III" (two cases), and "diffuse injury II" (seven cases) (Table 1) , according to the definitions of the Traumatic Coma Data Bank. 17 In all patients coma lasted longer than 5 days posttrauma. There were 13 male and two female patients in the group with a median age of 29 years (range 15-66 years). The median time of treatment in the intensive care unit (ICU) was 23 days. Monitoring of brain PtiO 2 was performed up to 12 days posttrauma (median 9 days), whereas jugular bulb catheters usually had to be removed after a median of 4 days (Table 1) .
Intensive Care Management and Organization of Study
In addition to the oxygenation parameters, the patients' electrocardiogram, arterial blood pressure, ICP, body temperature, arterial O 2 saturation (SaO 2 ), and end-tidal CO 2 were monitored in all cases. Measurement of ICP was performed using a fiberoptic intraparenchymal device (Camino Laboratories, San Diego, CA; Fig. 1 ). For combined analgesia and sedation a continuous infusion of fentanyl (0.05-0.5 mg/hour) and midazolam (2-15 mg/hour) was used.
The SjvO 2 monitoring was initiated 6 to 24 hours postinjury. A No. 7.5 French introducer was placed percutaneously into the internal jugular vein, on the right in 10 cases and on the left side in five cases, followed by a No. 5.5 French fiberoptic catheter (Swan-Ganz catheter, Pulmonary Opticath P575EH, Oximetrix-3 System; Abbott Laboratories, N. Chicago, IL). Prior to insertion, a calibration using the colorimetric method provided by the manufacturer was performed. A bedside x-ray film confirmed the catheter's tip position at the C-2 vertebral body. Routinely, saturation readings of the catheter were corrected every 12 hours if the in vitro determined oxygen saturation (CO-Oximeter IL-482; Instrumentation Laboratories, Watertown, MA) and the catheter's measurements differed by more than 5%. 10 To prevent blood clotting at the tip of the catheter, a heparinized saline solution was continuously infused (3 ml/hour). Within 12 hours postinjury a flexible polarographic Clark-type microcatheter (LICOX System; GMS mbH, Kiel, Germany) to be used for continuous brain PtiO 2 monitoring was inserted into the nonlesioned frontal white matter (Fig. 1 ). The catheter placement was guided by a specific introducer that was tightly fixed on a special skull screw. After insertion, the catheter was firmly Luer-locked onto the introducer. The insertion depth of the probe was 34 mm (from the level of the dura to the catheter tip). Proper location of the catheter was ascertained using a CT scan. The measured tissue surface area was approximately 17 mm 2 . Technical characteristics of this catheter include a stirring artifact of less than 4%, a response time T 90˚/35˚C of 70 seconds, and a sensitivity drift of Ϯ 1% per day. Brain PtiO 2 values were continuously averaged over a 500-sec period and adjusted to actual body core temperature by means of a computer (LICOX System; GMS mbH). Immediately after their removal from the brain, the PtiO 2 catheters were checked for correct PO 2 measurements.
To maintain an arterial PO 2 above 100 mm Hg, an appropriate fraction of inspired oxygen measuring between 0.35 and 0.55 was chosen. Hemoglobin concentration was maintained above 10 g/dl throughout the monitoring period. 6 Intracranial hypertension, defined as an ICP measuring 20 mm Hg or higher that lasted for more than 10 minutes, was treated by head elevation, moderate hyperventilation (PaCO 2 30-35 mm Hg), and intermittent boluses of mannitol up to a maximum of 3.5 g/kg body weight per 24 hours. Barbiturate-induced coma was used in cases of otherwise uncontrollable intracranial hypertension and guided by a burst-suppression electroencephalogram pattern (seven cases). If this treatment failed, a decompressive craniotomy was performed (two cases).
Usually, CPP was maintained above 70 mm Hg by treating the elevated ICP and by pharmacologically raising the mean arterial blood pressure (MABP) by administration of dopamine and noradrenaline.
Data Collection and Analysis
Analog signals of MABP (recorded from a radial arterial catheter leveled to the skull base), ICP, end tidal CO 2 (Capnometer model 14360; Hewlett Packard, Waltham, MA), SaO 2 by pulse oximetry (model 1020A; Hewlett Packard), brain PtiO 2 , and SjvO 2 were digitized at 0.1 Hz, then displayed, stored, and analyzed on a multimodal computer system with appropriate software (LabVIEW; National Instruments, Austin, TX) developed by one of the authors (T.F.B.). The CPP was calculated on line as the difference between MABP and ICP.
"Time of good data quality" was assessed off line by means of a stepwise procedure. Artifact detection was performed using a software routine (LabVIEW) that automatically limited data to a preset range that also allowed detection of obvious technical errors such as those caused by cable disconnection. Episodes of catheter malfunction (for example, dislocation or low light intensity of the jugular bulb catheter) were marked and saved in separate files. Additionally, all data were reviewed by a physician using a high-speed replay module of the monitoring program. All automatically marked episodes were reviewed in detail and excluded when clear evidence for their reliability could not be found. The total time of these episodes was determined separately for brain PtiO 2 and SjvO 2 . "Time of good data quality" was calculated by the formula: time of good data quality [%] = 100 Ϫ (time of artifacts (min) ϫ 100)/total monitoring time (min).
For correlation analysis, 18 events of a marked MABP decrease (3099 datasets, average duration 12 minutes (range 6-24 minutes)), with a consecutive drop in CPP were taken ( Fig. 2 and Table 2 ). Values were only used for analysis if the last calibration of SjvO 2 had been made less than 4 hours earlier and there was no "low light" alarm on the SjvO 2 monitor. Furthermore, episodes of marked cerebral hyperemia, defined as a SjvO 2 greater than 75%, were also excluded. The underlying mechanism of MABP reduction in one case was a cardiac arrest-successfully treated by cardiopulmonary resuscitation-and in a second case was withdrawal of a catecholamine infusion following an "end-of-life decision" because of a devastating intracranial situation (Fig. 3) . In five events technical difficulties with the catecholamine infusion caused arterial hypotension. In the remaining 11 episodes no obvious reasons for MABP reduction could be detected. Throughout these episodes, the SaO 2 was unchanged, whereas there was a reduction in end-tidal CO 2 caused by reduced pulmonary perfusion and thus reduced pulmonary CO 2 exchange (Figs. 2 and 3) .
Statistical Analysis
Statistical analysis was performed using a nonlinear regression computer program (Sigmaplot; Jandel Scientific, Corte Madera, CA) that ran the Marquardt-Levenberg algorithm (minimizing the sum of the squared differences of given parameters). Values are given as the mean Ϯ standard error of the mean unless otherwise indicated. A probability value of less than 0.01 was considered significant. Dotted lines appearing in the graphs in Fig. 4 indicate the 99% prediction interval.
Results
Safety and Data Quality of SjvO 2 and Brain PtiO 2
After removal of the PtiO 2 catheter from the brain the difference between the brain PtiO 2 and the calculated PO 2 in room air was low (5.5 Ϯ 1.1 mm Hg). These control measurements indicate that brain PtiO 2 catheters produce reliable data up to 12 days after insertion. Insertion of PtiO 2 catheters into brain tissue was not associated with infections or intracranial bleedings.
The difficulties encountered during SjvO 2 monitoring included poor light intensity and catheter dislocation. Repetitive calibrations, both routine and additional, had to be performed. Ninety-three of a total number of 170 calibrations (55%) revealed a difference between SjvO 2 -monitored saturation and CO 2 oximeter readings of more than 5%. Total SjvO 2 monitoring time was also short due to increasing periods of poor light intensity, which appeared more frequently the longer the monitoring lasted (Table  1) . Hence, no SjvO 2 measurements were obtainable beyond posttrauma Day 7.
The total monitoring time of PtiO 2 was twice as long as that of SjvO 2 ( Table 1) . The "time of good data quality" differed markedly (95% (2491 hours) in PtiO 2 ; 43% (607 hours) in SjvO 2 ).
Analysis of SjvO 2 and PtiO 2
A synopsis of all 18 episodes of reduced MABP used for correlation analysis is given in Table 2 . The average MABP reduction was 35.7 mm Hg. The response of ICP on MABP reduction was inconsistent. In 12 episodes ICP dropped simultaneously with the MABP reduction, whereas ICP increased in six events (Figs. 2 and 3 ). On average, ICP displayed a reduction of 9.3 mm Hg and CPP a reduction of 29.0 mm Hg (Table 2) . Cerebral oxygenation deteriorated by an average of 6.0 mm Hg in PtiO 2 and 9.9% in SjvO 2 ( Table 2) .
The correlation analysis of brain PtiO 2 versus SjvO 2 revealed a significant correlation (r 2 = 0.71) of the second order (Fig. 4 left) . In the range of 30% to 75% SjvO 2 , brain PtiO 2 dropped by approximately 0.5 mm Hg per 1% venous O 2 saturation decrease. At an SjvO 2 of 50%, brain PtiO 2 ranged from 3 to 12 mm Hg, the regression curve's best fit value being 8.5 mm Hg (Fig. 4 left) . An SjvO 2 of 30% was associated with a brain PtiO 2 close to 0 mm Hg and an SjvO 2 of 70% corresponded to a brain PtiO 2 of 20 mm Hg.
The analyses of CPP versus SjvO 2 and CPP versus PtiO 2 (Fig. 4 center and right) revealed a third-order regression curve and a close relationship of cerebral oxygenation and CPP below the breakpoint of 60 mm Hg. Above 60 mm Hg CPP cerebral oxygenation was grossly unaffected by CPP. 
Discussion
General Aspects of Monitoring of Cerebral Oxygenation
To detect impending cerebral ischemia in patients with severe head injuries, monitoring of MABP, ICP, and CPP as basic parameters of cerebral hemodynamics is imperative. There are situations, however, in which the ICP is normal and the CPP appears to be sufficient, but cerebral hypoxia may be present. Such episodes can be attributed to therapeutically induced hypocapnia or impaired arterial oxygen supply. 5, 24 Monitoring of cerebral oxygenation is capable of detecting harmful events, leading to hypoxic episodes that have been shown to exert negative effects on clinical outcome. 30 The first method used to monitor cerebral oxygenation in clinical examinations was jugular bulb oximetry. As an invasive technique it allows continuous assessment of SjvO 2 as an indicator of global cerebral oxygenation as well as calculation of arteriojugular venous O 2 content difference. 8, 26 Tissue O 2 tension measurement represents an invasive method to monitor local cerebral oxygenation. Thus far, there are only a few reports on its clinical use. 14, 15, 34 Finally, near-infrared spectroscopy (NIRS) has been introduced for noninvasive monitoring of cerebral oxygenation. 13, 18 This procedure has been shown to detect cerebral hypoxic events intraoperatively and in the neurointensive care setting. 11, 12 However, numerous problems exist. Measurements tend to be unstable and do not reliably reflect episodes of cerebral maloxygenation. 33 Moreover, the tissue volume monitored by this technique is undetermined. Although the optodes are positioned above the frontal region, the whole brain probably contributes to signal changes. However, the percentage distribution of venous, capillary, and arterial blood representing the NIRS signal is undefined. Nonetheless, NIRS is regarded as having an intermediate status between global (SjvO 2 ) and local (PtiO 2 ) methods to assess cerebral oxygenation. 18 Clearly, technical refinements have to be made before this method can be introduced into clinical routine for long-term monitoring. As a noninvasive and simple technique, it bears the most interesting potential for the future to monitor cerebral oxygenation.
Practicality and Reliability of Brain PtiO 2 and SjvO 2 Monitoring
Monitoring of SjvO 2 is prone to many technical problems and vigilance is required to obtain reliable data. Even with frequent recalibration and special attention, problems such as poor light intensity, head movements, spontaneous waves, or sudden changes remain the underlying causes of a rather low "time of good data quality," as has been shown by this and other studies. [8] [9] [10] 30 For correlation analysis, great attention was paid to eliminate such artifacts (see Clinical Material and Methods). In discussing the reliability of SjvO 2 data, the catheter's location (left or right) has to be considered. Stocchetti, et al., 32 found relevant discrepancies in bilateral SjvO 2 measurements. Robertson and associates, 25 on the other hand, moderated this problem and advise the physician to place the catheter in the jugular bulb that receives the highest flow, as does Dearden. 8 We followed these guidelines. In conclusion, the absolute value of a single SjvO 2 data point is of lesser diagnostic relevance than its trend over time. Also, the 50% threshold in SjvO 2 should be used cautiously, because there are no reports on increased arteriojugular venous lactate content difference below this threshold.
In contrast to the frequent recalibration required by jugular bulb oximetry, the brain PtiO 2 catheter only needs calibration prior to its insertion and no recalibration is necessary. Control measurements after removal demonstrate a good stability. During the monitoring time, there were nearly no artifacts. Based on these characteristics, brain PtiO 2 monitoring is more suitable for continuous and routine use than jugular bulb oximetry. Clearly, PtiO 2 monitoring is a local technique, as the measured tissue surface area of approximately 17 mm 2 demonstrates. It remains to be studied whether there are remarkable tissue O 2 tension differences between various regions or differences between "normal" and contused or infarcted tissue.
In this study it was verified by CT scanning that the probes were located within the frontal white matter without obvious pathology, suggesting that this area is largely unaffected by trauma. This ensures reliable PtiO 2 data acquisition because PtiO 2 in the cerebral white matter is regarded to be much more homogeneously distributed than in the cerebral gray matter. 31 The argument that the PtiO 2 probe could induce microvascular compression, thus underestimating the actual PtiO 2 , cannot be rejected. This may be a reason why Van Santbrink, et al., 34 found low PtiO 2 values early after insertion of the probe.
Critical Threshold in Monitoring Cerebral Oxygenation
In animal experiments (using cats and dogs) the PtiO 2 in cerebral white matter was found to be 25 to 30 mm Hg in noninjured tissue. 14, 15 There are no data on PtiO 2 in the cerebral white matter of healthy humans. In severely head injured patients without intracranial hypertension or CPP decrease, PtiO 2 was also found to be in the range of 25 to 30 mm Hg. 14, 15 Until the present, no hypoxic threshold in PtiO 2 monitoring has been defined. In one report on a series of 22 patients with severe head injuries, five of six patients with PtiO 2 values of 5 mm Hg or below died or stayed vegetative. 34 For the routine use of PtiO 2 monitoring in clinical practice, however, such a threshold should be identified as a guide for specific therapy. The 50% SjvO 2 threshold certainly does not represent a clearly delineated border because of side-to-side and interindividual differences as well as technical difficulties, as mentioned above. This may partially explain the variation in PtiO 2 (3-12 mm Hg) at the given 50% SjvO 2 . The scattering of brain PtiO 2 at a SjvO 2 of 50% (Fig. 4 left) may also be related to local or regional differences in PtiO 2 measurements. Based on the data presented we propose that a brain PtiO 2 of 10 mm Hg and lower should be considered "hypoxic" and thus should be treated vigorously, for example, by an induced elevation of CPP. Nevertheless, the significance of this PtiO 2 threshold on clinical outcome, as shown by Robertson 24 and Sheinberg and associates 30 for SjvO 2 monitoring, needs to be confirmed by further investigations.
Cerebral Oxygenation and Cerebral Perfusion Pressure
In the present study we also address the effect on cerebral oxygenation of a reduced CPP caused by a decline in systemic arterial blood pressure. Such events appear rather frequently in the treatment of severely head injured patients and arterial hypotension is accepted as a major mechanism of secondary brain damage. 3, 21 This has been confirmed by studies that involved continuous monitoring of SjvO 2 in which sudden drops in CPP were identified as causing cerebral O 2 desaturation and worsening outcome. 24, 30 In animals, the level of PtiO 2 was found to decrease continuously with a falling CPP. At a CPP of 40 mm Hg, known to be associated with a significantly decreased CBF, PtiO 2 was approximately 15 mm Hg and at a CPP of 20 mm Hg, PtiO 2 was found to be 10 mm Hg. 14, 15 To our knowledge, there are no comparable human data on PtiO 2 versus CPP available.
The results of correlation analyses of CPP versus SjvO 2 and CPP versus brain PtiO 2 strongly suggest a preserved cerebral autoregulation in these patients, although true tests for pressure autoregulation, for example, CBF measurements, have not been performed. Oxygenation parameters were stable if CPP was above 60 mm Hg. This finding of a presumably preserved cerebral autoregulation following severe head injury is in accordance with the observations of others. 2, 7, 28, 29 It represents the basis for the concept of a CPP-guided therapy for successful treatment of intracranial hypertension by raising systemic blood pressure, which would result in cerebral vasoconstriction and a compensatory ICP reduction. 28, 29 It is still under debate in the literature whether and how often autoregulation is disturbed after trauma and how this should be diagnosed. 23, 27, 29 In the present study there were only three events in which an impaired autoregulation might be postulated, because ICP and MABP decreased continuously while CPP remained in the normal autoregulatory range.
There is ongoing discussion about the CPP level necessary to guarantee sufficient CBF in severe head injury. Some authors assume that the cerebral autoregulation curve is depressed and shifted to the right after trauma. Hence, head-injured patients would need a CPP higher than 60 mm Hg to maintain CBF. 2, 19, 20, [27] [28] [29] The data we have presented on SjvO 2 and brain PtiO 2 suggest that a CPP of 60 mm Hg is always sufficient to maintain a "normal" cerebral oxygenation and that no improvement in SjvO 2 or PtiO 2 can be expected by raising the CPP above 60 mm Hg. The latter finding confirms recent results of Cruz, et al., 7 in which no changes in CBF and arteriojugular venous O 2 content difference were observed when CPP was in the range of 60 to 130 mm Hg. Below this level of 60 mm Hg cerebral oxygenation may decrease. This is true at least for the subacute posttraumatic period during which our measurements took place. However, it could well be that a higher CPP is necessary during the acute stage (within 24 hours posttrauma) if CBF were to be markedly reduced. 1 Chan, et al., 2 have advocated a CPP of 70 mm Hg to maintain a sufficient blood flow. This is based on the observation that below 70 mm Hg the pulsatility index measured by transcranial Doppler sonography increases and SjvO 2 starts to decline. These findings are close to our observations. Some studies focusing on outcome support even higher CPP levels. For example, McGraw 19 and Mendelow, et al., 20 reported better outcome if CPP is maintained above 80 mm Hg. Only larger trials could clarify whether these CPP levels are in fact beneficial. Nevertheless, the present study once again demonstrates the importance of strictly maintaining CPP above at least 60 mm Hg.
Conclusions
In analyzed episodes of monitoring patients with severe head injury, SjvO 2 and brain PtiO 2 were found to run parallel. A hypoxic threshold of 8.5 mm Hg PtiO 2 (range 3-12 mm Hg) correlating with a SjvO 2 of 50% was established. For clinical use, a threshold of 10 mm Hg is proposed.
Marked declines in MABP and reduced CPP below 60 mm Hg have a substantially negative effect on cerebral oxygenation in severely head injured patients. At a CPP of 60 mm Hg and above no improvement in cerebral oxygenation was observed.
Brain PtiO 2 monitoring is a useful addition to existing neuromonitoring methods. Hopefully, it will help to improve the management and final outcome of comatose patients.
